Irvine, CA, United States of America

David D Eveleth, Jr


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1992-1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: David D Eveleth, Jr: Innovator in Neurodegenerative Treatment

Introduction

David D Eveleth, Jr. is a notable inventor based in Irvine, CA. He has made significant contributions to the field of neurodegenerative treatments, holding 2 patents that focus on innovative methods for addressing complex medical conditions.

Latest Patents

One of his latest patents is titled "Method of treatment of neurodegeneration with calpain inhibitors." This invention provides a method for treating neurodegenerative pathologies in human patients. The method involves selecting a patient for monitoring the presence of a neurodegenerative pathology associated with enhanced Calpain activity. It includes monitoring the patient for signs of the onset or existence of such a pathology. Upon detection of any indicium, a therapeutically effective amount of a Peptide Ketoamide compound, or a pharmaceutically acceptable salt or derivative, is administered along with a suitable carrier. Additionally, the invention outlines further methods of treatment and pharmaceutical compositions utilizing Peptide Ketoamides, Peptide Ketoacids, and Peptide Ketoesters.

Another significant patent is focused on "Methods for detecting cellular pathology by assaying spectrin." This invention provides a method for detecting cellular pathology through an immunoassay that determines the presence of stable breakdown products of the cytoskeleton component spectrin. The process involves physically separating components from a sample of spectrin-containing cells and using antibodies reactive with the breakdown products to assess their presence. An assay, such as an ELISA, is performed to detect total spectrin immunoreactivity, indicating cellular death or degradation.

Career Highlights

David has worked with esteemed institutions such as the University of California and Cortex Pharmaceuticals, Inc. His work has significantly impacted the understanding and treatment of neurodegenerative diseases.

Collaborations

Throughout his career, David has collaborated with notable individuals, including Gary S Lynch and Peter A Seubert. These collaborations have contributed to the advancement of research in his field.

Conclusion

David D Eveleth, Jr. is a prominent inventor whose work in neurodegenerative treatment showcases his innovative spirit and dedication to improving human health. His contributions continue to influence the medical community and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…